Meet Accuprec Research Labs
at CPHI Milan 2026
Accelerating Pharmaceutical Innovation Through Scientific Excellence
Accuprec Research Labs Pvt. Ltd. is proud to participate in CPHI Milan 2026, one of the world’s premier pharmaceutical industry exhibitions. We warmly invite pharmaceutical companies, medical device manufacturers, biotechnology organizations, regulatory professionals and research partners to visit us at Booth 8F71 and explore our comprehensive analytical, preclinical and medical device testing solutions.
As a globally recognized Contract Research Organization (CRO), Accuprec combines scientific expertise, regulatory excellence and cutting-edge laboratory capabilities to accelerate product development—from early research to successful commercialization.
Whether you’re developing pharmaceuticals, biologics, medical devices, combination products or specialty formulations, our multidisciplinary team is ready to discuss customized testing strategies that support regulatory approvals and product success.
Event Details
Date
6–8 October 2026
Venue
Fiera Milano, Milan, Italy
Booth No.
8F71
Meet Our Experts at Booth 8F71
Our experienced leadership team will be available throughout the exhibition to discuss your projects, regulatory challenges and collaboration opportunities.
Dr. Rina Gokani
Director & CSO
Mr. Mayur Kandoriya
Director & CMOMr. Kamal Kardani
Manager – Analytical DevelopmentMr. Jinay Shah
Manager – Analytical DevelopmentOur experts are ready to provide scientific guidance, discuss analytical challenges and recommend customized solutions aligned with your development goals.
Schedule a One-on-One Meeting
Planning your visit to CPHI Milan?
Book a meeting with our scientific experts to discuss your analytical requirements, regulatory strategies and product development objectives.
Why Visit Accuprec at CPHI Milan 2026?
Visiting our booth gives you the opportunity to:
Discuss analytical and regulatory challenges with experienced scientists.
Explore our latest pharmaceutical and medical device testing capabilities.
Learn about advanced characterization techniques for complex drug products.
Discover solutions that accelerate global regulatory approvals.
Schedule one-on-one technical consultations.
Build strategic partnerships with one of India’s leading CROs.
Our Comprehensive Testing & Research Solutions
Nitrosamine & NDSRI Testing
Nitrosamine impurities have become one of the pharmaceutical industry’s most critical regulatory concerns. Global health authorities require manufacturers to identify, quantify and control nitrosamine contamination in pharmaceutical products.
Our advanced analytical platforms enable highly sensitive detection at trace concentrations while ensuring compliance with global regulatory expectations.
View ServiceOur Capabilities
- Nitrosamine Risk Assessment
- NDSRI (Nitrosamine Drug Substance Related Impurities) Analysis
- Method Development & Validation
- Trace-Level Impurity Detection
- Stability Evaluation
- Regulatory Documentation Support
Extractables & Leachables (E&L) with Toxicological Risk Assessment (TRA)
Packaging materials, manufacturing components and drug delivery systems may introduce unwanted chemicals into pharmaceutical products. Our comprehensive E&L studies help manufacturers identify and mitigate these risks.
These studies help ensure patient safety while meeting international regulatory expectations.
Applications
- Primary Packaging
- Medical Devices
- Drug Delivery Systems
- Single-Use Systems
- Plastic Components
- Elastomers
- Manufacturing Equipment
Services Include
- Extractables Profiling
- Leachables Identification
- Unknown Compound Characterization
- Toxicological Risk Assessment (TRA)
- Regulatory Reporting
- Method Development
Toxicological & Preclinical Testing
Accuprec offers scientifically designed toxicological and preclinical studies that support drug discovery, product development and regulatory submissions.
Our experienced scientists deliver reliable data that supports informed development decisions while maintaining internationally accepted scientific standards.
View ServiceOur Expertise
- Acute Toxicity Studies
- Repeat-Dose Toxicity
- Safety Pharmacology
- Biocompatibility Assessments
- Histopathology
- Toxicokinetic Studies
- Specialized Toxicological Evaluations
Iron Carbohydrate Complex Characterization
Characterization of iron carbohydrate complexes requires advanced analytical techniques due to their structural complexity.
These studies support biosimilar development, quality control and regulatory submissions.
View ServiceOur Analytical Capabilities
- Physicochemical Characterization
- Particle Size Analysis
- Molecular Profiling
- Iron Release Studies
- Comparative Characterization
- Structural Evaluation
Carrier Vesicle-Based Particle Characterization (Liposomes & Nanosomes)
Nanotechnology-based drug delivery systems require detailed characterization to ensure quality, efficacy and stability.
These services support formulation development and regulatory approval.
We Characterize
- Liposomes
- Nanosomes
- Nanoparticles
- Carrier Vesicles
- Drug-Loaded Nanoformulations
Testing Includes
- Particle Size Distribution
- Zeta Potential
- Morphological Analysis
- Drug Encapsulation Efficiency
- Stability Assessment
- Surface Characterization
IVRT & IVPT Studies
In Vitro Release Testing (IVRT) and In Vitro Permeation Testing (IVPT) are essential for evaluating topical and transdermal pharmaceutical products.
Our studies support generic product development, formulation optimization and lifecycle management.
IVRT Services
- Drug Release Profiling
- Comparative Release Studies
- Method Development
- Method Validation
- Quality Control Testing
IVPT Services
- Skin Permeation Studies
- Bioequivalence Support
- Product Comparison
- Formulation Optimization
- Regulatory Documentation
Method Development & Validation
Accuprec develops robust analytical methods that comply with international regulatory standards.
We follow globally accepted guidelines to ensure reproducibility, precision, accuracy and reliability.
View ServiceOur Services
- Analytical Method Development
- Method Optimization
- Method Validation
- Method Transfer
- Forced Degradation Studies
- Stability-Indicating Methods
- Cleaning Validation Methods
Pre-filled Syringe Testing (ISO 11040)
Pre-filled syringes require extensive testing to ensure safety, functionality and regulatory compliance throughout their lifecycle.
Our comprehensive evaluations help manufacturers maintain product quality and regulatory compliance.
View ServiceOur Testing Services
- Functional Performance Testing
- Dimensional Analysis
- Container Closure Integrity
- Extractables & Leachables
- Mechanical Testing
- Compatibility Studies
- ISO 11040 Compliance Support
A Trusted CRO for Pharmaceutical & Medical Device Testing
Accuprec has established a strong global reputation by delivering high-quality scientific services to pharmaceutical, biotechnology and medical device companies.
Our multidisciplinary scientific team collaborates closely with clients to develop customized testing programs that align with project timelines and international regulatory requirements.
We Support
- Pharmaceutical Research
- Medical Device Testing
- Combination Products
- Biotechnology Products
- Specialty Chemicals
- Drug Delivery Systems
- Regulatory Consulting Support
Our Strengths
- Experienced Scientific Professionals
- State-of-the-Art Analytical Instrumentation
- Customized Testing Solutions
- Global Regulatory Expertise
- Comprehensive Documentation
- Fast Project Turnaround
- Reliable Technical Support
- Dedicated Project Management
Why Choose Accuprec Research Labs?
Choosing Accuprec means partnering with a CRO committed to scientific excellence and regulatory confidence.
We are committed to delivering accurate, reproducible and regulatory-compliant results that help bring safe and effective healthcare products to market.
Planning to Attend CPHI Milan 2026?
Let’s connect at Booth 8F71 and discuss how Accuprec can support your next pharmaceutical, biotechnology or medical device project.
Date
6–8 October 2026
Venue
Fiera Milano, Milan, Italy
Booth No.
8F71
We look forward to meeting pharmaceutical innovators, medical device manufacturers, biotechnology companies and research organizations from around the world while exploring opportunities for long-term scientific collaboration.
Schedule a Meeting or Connect with Our Team